معرفی
Jonathan Broder is a Research Fellow at the Monash University Clinical Trials Centre, Monash University, specializing in aging-related clinical research with over 24 publications between 2020-2025. His work primarily focuses on medication effects in elderly populations through large-scale studies like the ASPirin in Reducing Events in the Elderly (ASPREE) trial.
His research interests center on geriatric pharmacology, diabetes complications, and cardiovascular outcomes in aging. Key areas include cognitive decline linked to antibiotic use, frailty patterns in diabetic elderly, and long-term impacts of aspirin/metformin on cancer mortality. His methodology frequently employs pharmacoepidemiological approaches and target trial emulations to analyze real-world clinical data.
Broder's publication trends reveal consistent focus on medication safety in elderly populations, with recent work examining aspirin cessation consequences and diabetes treatment regimens. His research demonstrates strong interdisciplinary collaboration across geriatrics, oncology, and cardiology fields, often addressing UN Sustainable Development Goals related to health longevity.
He currently serves as Associate Investigator for the AUTOMATE ME project (2026-2030), a major melanoma screening initiative led by V. Mar, collaborating with institutions including the University of Queensland and Royal Prince Alfred Hospital. His work has garnered significant attention, with one 2024 publication covered by 43 news outlets and widely shared across academic social media platforms.
